These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18372526)

  • 1. Increased prostaglandin H synthase-1 expression and activity level in stably Harvey-ras transfected C3H10T1/2 cells.
    Xu X; Burgess JR; Teegarden D
    Cancer Lett; 1997 Oct; 119(1):87-92. PubMed ID: 18372526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfection of C3H10T1/2 cells with the Harvey-ras oncogene reduces cytosolic phospholipase A2 function.
    Teegarden D; Xu X; Burgess JR
    Cancer Lett; 1996 Oct; 107(1):59-64. PubMed ID: 8913267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-dihydroxyvitamin D inhibits vitamin E succinate-induced apoptosis in C3H10T1/2 cells but not Harvey ras-transfected cells.
    Stedman L; Nickel KP; Castillo SS; Andrade J; Burgess JR; Teegarden D
    Nutr Cancer; 2003; 45(1):93-100. PubMed ID: 12791509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of prostaglandin H synthase 1 and 2 in MyoD transfected cells.
    Steiner SM; Hu Y; Steiner MR
    Exp Cell Res; 1995 May; 218(1):389-93. PubMed ID: 7737375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of nuclear vitamin D receptor resistance in Harvey-ras-transfected cells.
    Taber LM; Adams LS; Teegarden D
    J Nutr Biochem; 2009 Aug; 20(8):629-37. PubMed ID: 18829283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma protein (pRB) was significantly phosphorylated through a Ras-to-MAPK pathway in mutant K-ras stably transfected human adrenocortical cells.
    Chen YF; Chiu HH; Wu CH; Wang JY; Chen FM; Tzou WH; Shin SJ; Lin SR
    DNA Cell Biol; 2003 Oct; 22(10):657-64. PubMed ID: 14611687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts.
    Quincoces AF; León J
    Cell Growth Differ; 1995 Mar; 6(3):271-9. PubMed ID: 7794795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal levels of max are sufficient for the cotransformation of C3H10T1/2 cells by ras and myc.
    Davenport EA; Taparowsky EJ
    Exp Cell Res; 1992 Oct; 202(2):532-40. PubMed ID: 1397104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive autoregulation of ras genes expression in fibroblasts.
    Quincoces AF; Polanco I; Thomson T; León J
    FEBS Lett; 1997 Oct; 416(3):317-23. PubMed ID: 9373177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal prostaglandin E2 synthase 1 expression in basic calcium phosphate crystal-stimulated fibroblasts: role of prostaglandin E2 and the EP4 receptor.
    Molloy ES; Morgan MP; Doherty GA; McDonnell B; O'Byrne J; Fitzgerald DJ; McCarthy GM
    Osteoarthritis Cartilage; 2009 May; 17(5):686-92. PubMed ID: 19010065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells.
    Taylor MT; Lawson KR; Ignatenko NA; Marek SE; Stringer DE; Skovan BA; Gerner EW
    Cancer Res; 2000 Dec; 60(23):6607-10. PubMed ID: 11118042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes.
    Benito M; Porras A; Nebreda AR; Santos E
    Science; 1991 Aug; 253(5019):565-8. PubMed ID: 1857988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
    Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
    Carbone A; Gusella GL; Radzioch D; Varesio L
    Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic potential of BRAF versus RAS.
    Benjamin CL; Ananthaswamy HN
    Cancer Lett; 2008 Mar; 261(2):137-46. PubMed ID: 18280030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harboring Harvey ras gene alterations.
    Diaz-Guerra M; Haddow S; Bauluz C; Jorcano JL; Cano A; Balmain A; Quintanilla M
    Cancer Res; 1992 Feb; 52(3):680-7. PubMed ID: 1370649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of prostaglandin G/H synthase expression in mesangial cells transfected by pp60c-src proto-oncogene.
    Reiser CO; Marx M; Hoppe J; Goppelt-Struebe M
    Exp Cell Res; 1996 Feb; 222(2):304-11. PubMed ID: 8598218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of NIH3T3 cells with ras oncogenes abrogates the retinoic acid induction of tissue transglutaminase.
    Kosa K; Meyers K; De Luca LM
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1025-33. PubMed ID: 7504461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of mRuby2-Transfected C3H10T1/2 Fibroblasts for Musculoskeletal Tissue Engineering.
    Ker DF; Sharma R; Wang ET; Yang YP
    PLoS One; 2015; 10(9):e0139054. PubMed ID: 26407291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland.
    Thompson TA; Kim K; Gould MN
    Cancer Res; 1998 Nov; 58(22):5097-104. PubMed ID: 9823318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.